​

BIO-FD&C Co.,Ltd.

KOSDAQ:A251120 Stock Report

Market Cap: ₩168.4b

BIO-FD&CLtd (A251120) Stock Overview

Develops active ingredients for anti-aging cosmetics in South Korea. More details

A251120 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Risk Analysis

No risks detected for A251120 from our risk checks.

A251120 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

BIO-FD&C Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for BIO-FD&CLtd
Historical stock prices
Current Share Price₩19,050.00
52 Week High₩23,100.00
52 Week Low₩12,230.00
Beta0.79
1 Month Change13.60%
3 Month Change40.59%
1 Year Change11.80%
3 Year Change-13.21%
5 Year Changen/a
Change since IPO-14.19%

Recent News & Updates

There's Reason For Concern Over BIO-FD&C Co.,Ltd.'s (KOSDAQ:251120) Massive 30% Price Jump

Jun 18
There's Reason For Concern Over BIO-FD&C Co.,Ltd.'s (KOSDAQ:251120) Massive 30% Price Jump

BIO-FD&CLtd's (KOSDAQ:251120) Soft Earnings Are Actually Better Than They Appear

May 23
BIO-FD&CLtd's (KOSDAQ:251120) Soft Earnings Are Actually Better Than They Appear

Recent updates

There's Reason For Concern Over BIO-FD&C Co.,Ltd.'s (KOSDAQ:251120) Massive 30% Price Jump

Jun 18
There's Reason For Concern Over BIO-FD&C Co.,Ltd.'s (KOSDAQ:251120) Massive 30% Price Jump

BIO-FD&CLtd's (KOSDAQ:251120) Soft Earnings Are Actually Better Than They Appear

May 23
BIO-FD&CLtd's (KOSDAQ:251120) Soft Earnings Are Actually Better Than They Appear

With EPS Growth And More, BIO-FD&CLtd (KOSDAQ:251120) Makes An Interesting Case

Dec 16
With EPS Growth And More, BIO-FD&CLtd (KOSDAQ:251120) Makes An Interesting Case

We Think That There Are Some Issues For BIO-FD&CLtd (KOSDAQ:251120) Beyond Its Promising Earnings

Nov 19
We Think That There Are Some Issues For BIO-FD&CLtd (KOSDAQ:251120) Beyond Its Promising Earnings

Some Shareholders Feeling Restless Over BIO-FD&C Co.,Ltd.'s (KOSDAQ:251120) P/E Ratio

Oct 14
Some Shareholders Feeling Restless Over BIO-FD&C Co.,Ltd.'s (KOSDAQ:251120) P/E Ratio

A Look At The Fair Value Of BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

Aug 06
A Look At The Fair Value Of BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

Shareholder Returns

A251120KR BiotechsKR Market
7D-3.8%4.3%3.3%
1Y11.8%28.1%8.7%

Return vs Industry: A251120 underperformed the KR Biotechs industry which returned 28.1% over the past year.

Return vs Market: A251120 exceeded the KR Market which returned 8.7% over the past year.

Price Volatility

Is A251120's price volatile compared to industry and market?
A251120 volatility
A251120 Average Weekly Movement6.4%
Biotechs Industry Average Movement8.3%
Market Average Movement5.6%
10% most volatile stocks in KR Market11.7%
10% least volatile stocks in KR Market2.8%

Stable Share Price: A251120 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A251120's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005n/aSang-Hyun Mowww.biofdnc.com

BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, herbal extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, skin moisturizing, anti-inflammation/skin soothing, and anti-oxidation.

BIO-FD&C Co.,Ltd. Fundamentals Summary

How do BIO-FD&CLtd's earnings and revenue compare to its market cap?
A251120 fundamental statistics
Market cap₩168.44b
Earnings (TTM)₩5.05b
Revenue (TTM)₩16.59b
32.8x
P/E Ratio
10.0x
P/S Ratio

Is A251120 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A251120 income statement (TTM)
Revenue₩16.59b
Cost of Revenue₩4.93b
Gross Profit₩11.66b
Other Expenses₩6.61b
Earnings₩5.05b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)580.79
Gross Margin70.28%
Net Profit Margin30.44%
Debt/Equity Ratio1.9%

How did A251120 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/16 10:24
End of Day Share Price 2025/07/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BIO-FD&C Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eui-Seob ShimNH Investment & Securities Co., Ltd.